Sano Kazumi, Yoshikawa Megumi, Hayasaka Shinya, Satake Kurita, Ikegami Yoji, Yoshida Hisahiro, Ishikawa Toshihisa, Sawada Seigo, Tanabe Shinzo
Department of Drug Metabolism and Disposition, Meiji Pharmaceutical University, 204-8588 Tokyo, Japan.
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Sep 25;795(1):25-34. doi: 10.1016/s1570-0232(03)00485-9.
SN-38 (7-ethyl-10-hydroxycamptothecin) is an active metabolite derived from the semi-synthetic compound camptothecin (CPT) named Irinotecan (CPT-11). The antitumor activity of SN-38 is 1000-fold more potent than the parent CPT-11. Fourteen new derivatives of camptothecin have recently been developed by Yakult Honsha (Tokyo, Japan). Here we describe a simple and cost-effective high-performance liquid chromatography (HPLC) method without an ion-pairing agent, which allows the simultaneous determination of both lactone and carboxylate forms of SN-38 and other camptothecin derivatives. A weak linear relationship between the HPLC retention factors (ln k') and the cellular concentrations of these compounds was observed. These results suggest that low-polarity compounds easily accumulate in cancer cells and may circumvent drug resistance. The HPLC analysis herein described is expected to greatly assist in derivative synthesis and chemical modification of camptothecin-based antitumor drugs.
SN-38(7-乙基-10-羟基喜树碱)是一种活性代谢产物,源自名为伊立替康(CPT-11)的半合成化合物喜树碱(CPT)。SN-38的抗肿瘤活性比母体CPT-11强1000倍。养乐多本社(日本东京)最近研发了14种喜树碱新衍生物。在此,我们描述了一种无需离子对试剂的简单且经济高效的高效液相色谱(HPLC)方法,该方法可同时测定SN-38及其他喜树碱衍生物的内酯和羧酸盐形式。观察到HPLC保留因子(ln k')与这些化合物的细胞浓度之间存在微弱的线性关系。这些结果表明,低极性化合物容易在癌细胞中蓄积,并且可能规避耐药性。本文所述的HPLC分析有望极大地助力基于喜树碱的抗肿瘤药物的衍生物合成及化学修饰。